Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report

Epidermal growth factor receptor (EGFR) mutations have been frequently detected in patients with pulmonary adenocarcinoma. EGFR Exon 19Del and 21L858R mutations are the two most common EGFR mutations. EGFR-tyrosine kinase inhibitors (TKIs) are widely employed to treat patients with non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongming, Wu, Zhijun, Du, Yangfeng, Wu, Tao, Tian, Wei, Dong, Wen, Cai, Juan, Zheng, Jiang, Zhang, Yan, Li, Shiyan, Xu, Wei, Qin, Jing, Xiao, Zemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036817/
https://www.ncbi.nlm.nih.gov/pubmed/36969031
http://dx.doi.org/10.3389/fonc.2023.1145021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036817/
https://www.ncbi.nlm.nih.gov/pubmed/36969031
http://dx.doi.org/10.3389/fonc.2023.1145021

Ejemplares similares